canada generic semaglutide Wegovy: approves first version for weight loss Health Canada has approved a

Victoza: Contains liraglutide, another GLP-1 receptor agonist similar to semaglutide

Versus sulphonylureas (such as gliclazide), GLP-1 receptor agonists offer comparable glucose-lowering efficacy but with significantly lower hypoglycaemia risk and the advantage of weight loss rather than weight gain

Low blood sugar Alcohol can decrease blood sugar levels, especially in people taking medications that can lower blood sugar

Its also not FDA approved, since its considered a supplement, not a medication

GLP-1 receptor agonists should be used cautiously in patients with severe gastrointestinal disease or previous pancreatitis